A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
Conditions
Solid Tumor
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UC San Diego Moores Cancer Center, La Jolla, California, United States
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
Yale Cancer Center, New Haven, Connecticut, United States
Florida Cancer Specialist-Lake Mary, Lake Mary, Florida, United States
University of Illinois, Chicago, Illinois, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
START - Midwest - EDOS, Grand Rapids, Michigan, United States
Montefiore Einstein Cancer Center, The Bronx, New York, United States
Mary Crowley Medical Research Center, Dallas, Pennsylvania, United States
Abramson Cancer Center;Univ of Pennsylvania, Philadelphia, Pennsylvania, United States
SCRI Oncology Partners, Nashville, Tennessee, United States
O'Quinn Medical Tower at McNair Campus, Houston, Texas, United States
St Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia
Peter Maccallum Cancer Centre, Parkville, Victoria, Australia
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Sir Mortimer B Davis Jewish General Hospital, Montreal, Quebec, Canada
Institut Bergonie, Bordeaux, France
Rambam Health Care Campus, Haifa, Israel
Hadassah University Hospital - Ein Kerem, Jerusalem, Israel
The Chaim Sheba Medical Center, Ramat Gan, Israel
Tel Aviv Sourasky Medical Center PPDS, Tel Aviv, Israel
National University Hospital, Singapore, Singapore
National Cancer Centre, Singapore, Singapore
Seoul National University Bundang Hospital, Seongnam, South Korea
Asan Medical Center., Seoul, South Korea
Seoul National University Hospital, Seoul, South Korea
Severance Hospital, Yonsei University Health System, Seoul, South Korea
Instituto de Investigacion Oncologica Vall dHebron (VHIO) - EPON, Barcelona, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
START Madrid_Hospital Universitario HM Sanchinarro_CIOCC, Madrid, Spain
Hospital Universitario Virgen de la Victoria, Málaga, Spain
Hospital Universitario Virgen del Rocio - PPDS, Seville, Spain
Hospital Clinico Universitario de Valencia, Valencia, Spain
Western General Hospital;Edinburgh Cancer Center, Edinburgh, Midlothian, United Kingdom
NIHR UCLH Clinical Research Facility, London, United Kingdom
The Christie, Manchester, United Kingdom
Royal Marsden Hospital - Surrey, Sutton, United Kingdom
Study leads
Clinical Trials
Study Director
Hoffmann-La Roche